Brain Tumor Vaccines

Peptide and dendritic cell vaccines activate the immune system against tumor antigens to combat brain tumors. Vaccines stimulate a systemic immune response by inducing both antitumor T cells as well as humoral immunity through antibody production to cross the blood –brain barrier and combat brain tumors. Recent trials investigating vaccines against peptides (ie, epithelial growth factor receptor variant III, survivin, heat shock proteins, or personalized tumor antigens) and dendritic cells pulsed with known peptides, messenger RNA or unknown tumor lysate tar gets demonstrate the potential for therapeutic cancer vaccines to become an important therapy for brain tumor treatment.
Source: Neurosurgery Clinics of North America - Category: Neurosurgery Authors: Source Type: research